Abstract
Background: Although most transthoracic echocardiograms (TTEs) performed today meet Appropriate Use Criteria (AUC), the ability of AUC to predict whether these TTEs will impact clinical management remains unclear. Methods: The charts of 143 consecutive inpatient or outpatient TTEs at an academic medical center were retrospectively reviewed. Patients with a history of cardiac transplant or left ventricular assist device, or with inadequate pre-/ post- TTE clinical documentation were excluded; 123 studies were analyzed. Each TTE was assigned an AUC, pre-test, and clinical impact category. TTE indications were assigned by a cardiologist blinded to pre-study and post-study clinical data and categorized as: 1) inappropriate; 2) appropriate; or 3) uncertain based on 2011 AUC. Pre-test clinical course was analyzed by two independent cardiologists blinded to AUC and post-TTE clinical course and categorized as 1) TTE should not be performed, 2) TTE would likely alter clinical management, 3) TTE should be performed for reassurance/ continuity of care. Post-test clinical course was analyzed by two independent cardiologists blinded to AUC and pre-test assignment and categorized as 1) TTE did not alter clinical management, 2) TTE led to active change in management, 3) TTE led solely to reassurance/ continuity of current care. Results: By 2011 AUC, 85% of studies were appropriate, 11% were inappropriate, and 4% were uncertain. Active change resulted from 30% of studies, while 49% of studies provided reassurance/ continuity of care, and 21% had no clinical impact. These proportions were not statistically significant across AUC categories (p=0.54). Pretest clinical assessment suggested that 31% should not have been performed, 63% should have been performed for reassurance / continuity of care alone, and 7% were likely to alter clinical management. These pretest assessments were significantly associated with impact on clinical management (p=0.0067), with 75% (n=6/8) of those studies expected to alter clinical management actually doing so, 56% (n=43/77) of those predicted to primarily result in reassurance actually doing so, and 37% (n=14/38) of those predicted not to alter clinical management actually having no clinical impact. Conclusions: Classification by AUC is not associated with clinical impact. Although classification by pre-test probability is associated with clinical impact, a significant number of studies not predicted to have clinical impact actually had clinical impact. Further studies on methods to improve prediction of clinical utility for transthoracic echocardiography are warranted.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.